Last reviewed · How we verify
Prevent Minor Bacterial Skin Infection
Approved treatments
- Lignocaine · University of Malaya
- Lignospan Forte · Fresenius Kabi
Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction. - Benzetonium Chloride
- Dyclone
- Benzododecinium
- Norcaine
- pramocaine
- Lidocain · Bayer
- xylocain · Saint-Joseph University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevent Minor Bacterial Skin Infection patent landscape — cliff calendar, originator estates, attackable patents
- Prevent Minor Bacterial Skin Infection treatment landscape brief
- Prevent Minor Bacterial Skin Infection treatment updates RSS
Frequently asked questions about Prevent Minor Bacterial Skin Infection
What drugs treat Prevent Minor Bacterial Skin Infection?
Tracked treatments include Lignocaine, Lignospan Forte, Benzetonium Chloride, Dyclone, Benzododecinium, Norcaine, pramocaine, Lidocain.
What is the treatment for Prevent Minor Bacterial Skin Infection?
Standard treatment for Prevent Minor Bacterial Skin Infection includes Lignocaine, Lignospan Forte, Benzetonium Chloride, Dyclone, Benzododecinium. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevent Minor Bacterial Skin Infection patent cliff · Prevent Minor Bacterial Skin Infection CI report
- Treatment: Lignocaine · University of Malaya
- Treatment: Lignospan Forte · Fresenius Kabi
- Treatment: Benzetonium Chloride
- Treatment: Dyclone
- Treatment: Benzododecinium
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing